An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy Review uri icon


MeSH Major

  • Brain Neoplasms
  • Radiosurgery


  • As our surgical, radiation, chemotherapeutic and supportive therapies for brain malignancies improve, and overall survival is prolonged, appropriate symptom management in this patient population becomes increasingly important. This review summarizes the published literature and current practice patterns regarding prophylactic and perioperative anti-epileptic drug use. As a wide range of anti-epileptic drugs is now available to providers, evidence guiding appropriate anticonvulsant choice is reviewed. A particular focus of this article is radiation therapy for brain malignancies. Toxicities and seizure risk associated with cranial irradiation will be discussed. Epilepsy management in patients undergoing radiation for gliomas, glioblastoma multiforme, and brain metastases will be addressed. An emerging but inconsistent body of evidence, reviewed here, indicates that anti-epileptic medications may increase radiosensitivity, and therefore improve clinical outcomes, specifically in glioblastoma multiforme patients.

publication date

  • August 2019



  • Review



  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.seizure.2019.06.019

PubMed ID

  • 31247400

Additional Document Info

start page

  • 30

end page

  • 37


  • 70